397 related articles for article (PubMed ID: 28040475)
1. The low-risk papillomaviruses.
Egawa N; Doorbar J
Virus Res; 2017 Mar; 231():119-127. PubMed ID: 28040475
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Brd4 in different steps of the papillomavirus life cycle.
Iftner T; Haedicke-Jarboui J; Wu SY; Chiang CM
Virus Res; 2017 Mar; 231():76-82. PubMed ID: 27965149
[TBL] [Abstract][Full Text] [Related]
3. Activation of telomerase by HPVs.
Katzenellenbogen RA
Virus Res; 2017 Mar; 231():50-55. PubMed ID: 27863966
[TBL] [Abstract][Full Text] [Related]
4. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.
Graham SV
Clin Sci (Lond); 2017 Sep; 131(17):2201-2221. PubMed ID: 28798073
[TBL] [Abstract][Full Text] [Related]
5. Genomic characterization of a novel human papillomavirus (HPV-117) with a high viral load in a persisting wart.
Köhler A; Gottschling M; Förster J; Röwert-Huber J; Stockfleth E; Nindl I
Virology; 2010 Mar; 399(1):129-133. PubMed ID: 20096912
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
7. Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency.
Pastrana DV; Peretti A; Welch NL; Borgogna C; Olivero C; Badolato R; Notarangelo LD; Gariglio M; FitzGerald PC; McIntosh CE; Reeves J; Starrett GJ; Bliskovsky V; Velez D; Brownell I; Yarchoan R; Wyvill KM; Uldrick TS; Maldarelli F; Lisco A; Sereti I; Gonzalez CM; Androphy EJ; McBride AA; Van Doorslaer K; Garcia F; Dvoretzky I; Liu JS; Han J; Murphy PM; McDermott DH; Buck CB
mSphere; 2018 Dec; 3(6):. PubMed ID: 30541782
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus infections and oral tumors.
Syrjänen S
Med Microbiol Immunol; 2003 Aug; 192(3):123-8. PubMed ID: 12920585
[TBL] [Abstract][Full Text] [Related]
9. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus molecular biology and disease association.
Doorbar J; Egawa N; Griffin H; Kranjec C; Murakami I
Rev Med Virol; 2015 Mar; 25 Suppl 1(Suppl Suppl 1):2-23. PubMed ID: 25752814
[TBL] [Abstract][Full Text] [Related]
11. The biology and life-cycle of human papillomaviruses.
Doorbar J; Quint W; Banks L; Bravo IG; Stoler M; Broker TR; Stanley MA
Vaccine; 2012 Nov; 30 Suppl 5():F55-70. PubMed ID: 23199966
[TBL] [Abstract][Full Text] [Related]
12. [Virological and carcinogenic aspects of HPV].
Prétet JL; Charlot JF; Mougin C
Bull Acad Natl Med; 2007 Mar; 191(3):611-23; discussion 623. PubMed ID: 18072657
[TBL] [Abstract][Full Text] [Related]
13. Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia.
Egawa N; Egawa K; Griffin H; Doorbar J
Viruses; 2015 Jul; 7(7):3863-90. PubMed ID: 26193301
[TBL] [Abstract][Full Text] [Related]
14. Single-cell RNA sequencing reveals cell type-specific HPV expression in hyperplastic skin lesions.
Devitt K; Hanson SJ; Tuong ZK; McMeniman E; Soyer HP; Frazer IH; Lukowski SW
Virology; 2019 Nov; 537():14-19. PubMed ID: 31425970
[TBL] [Abstract][Full Text] [Related]
15. Type 2 human papillomavirus E7 attenuates E-cadherin expression in human keratinocytes.
Song JY; Park YM; Choi SY
J Microbiol; 2021 Jun; 59(6):616-625. PubMed ID: 33779957
[TBL] [Abstract][Full Text] [Related]
16. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Tiling Array Analysis of HPV-Induced Warts Reveals Aberrant Methylation of Protein-Coding and Non-Coding Regions.
Al-Eitan LN; Alghamdi MA; Tarkhan AH; Al-Qarqaz FA
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31892232
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the DNA damage response during the life cycle of human papillomaviruses.
Anacker DC; Moody CA
Virus Res; 2017 Mar; 231():41-49. PubMed ID: 27836727
[TBL] [Abstract][Full Text] [Related]
19. Characterization of type-specific HPV prevalence in a population of persistent cutaneous warts in Flanders, Belgium.
Redzic N; Pereira AR; Menon S; Bogers J; Coppens A; Kehoe K; Vanden Broeck D
Sci Rep; 2023 Oct; 13(1):17492. PubMed ID: 37840107
[TBL] [Abstract][Full Text] [Related]
20. Review: antibodies to cutaneous human papillomaviruses.
Antonsson A
J Med Virol; 2012 May; 84(5):814-22. PubMed ID: 22431031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
